Expert Case Discussions on Age-Related Macular Degeneration and Geographic Atrophy
Ophthalmology
Curriculum:
Expert Case Discussions on Age-Related Macular Degeneration (AMD) and Geographic Atrophy (GA)
Expert Case Discussions on Age-Related Macular Degeneration (AMD) and Geographic Atrophy (GA)
Credits:
1 AMA PRA Category 1 Credit(s) ™
1 AMA PRA Category 1 Credit(s) ™
Launch Date:
September 29, 2015
September 29, 2015
Expiration Date:
The accreditation for this activity has expired.
The accreditation for this activity has expired.
Primary Audience:
This activity intends to educate retina specialists and other ophthalmologists who care for patients with wet and dry AMD.
Relevant Terms:
Age-Related Macular Degeneration, Geographic Atrophy
Carl Regillo, MD
Carl Regillo, MD
Director, Retina Service
Wills Eye Hospital
Professor of Ophthalmology
Thomas Jefferson University
Philadelphia, Pennsylvania
Bio
Carl Regillo, MDDirector, Retina Service
Wills Eye Hospital
Professor of Ophthalmology
Thomas Jefferson University
Philadelphia, Pennsylvania
Pravin U. Dugel, MD
Pravin U. Dugel, MD
Clinical Professor of Ophthalmology
USC Eye Institute, Keck School of Medicine
University of Southern California
Los Angeles, California
Managing Partner
Retinal Consultants of Arizona, Ltd
Phoenix, Arizona
Bio
Pravin U. Dugel, MDClinical Professor of Ophthalmology
USC Eye Institute, Keck School of Medicine
University of Southern California
Los Angeles, California
Managing Partner
Retinal Consultants of Arizona, Ltd
Phoenix, Arizona
SriniVas R. Sadda, MD
SriniVas R. Sadda, MD
Doheny Eye Center UCLA–Arcadia
622 W. Duarte Road, Suite 101
Arcadia, California
Bio
SriniVas R. Sadda, MDDoheny Eye Center UCLA–Arcadia
622 W. Duarte Road, Suite 101
Arcadia, California
Rishi Singh, MD
Rishi Singh, MD
Medical Director, Clinical Systems Office (CSO)
Cleveland Clinic
Cleveland, Ohio
Bio
Rishi Singh, MDMedical Director, Clinical Systems Office (CSO)
Cleveland Clinic
Cleveland, Ohio
| 1. | Describe the pathogenesis of dry AMD | 2. | Incorporate current data on dietary supplements into communication and management strategies for patients with dry AMD |
| 3. | Discuss the efficacy and safety of agents currently in clinical trials for geographic atrophy | 4. | Compare the safety and efficacy of anti-VEGF therapies for wet AMD |
| 5. | Apply individualized management strategies for patients with wet AMD |
| 1. | Describe the pathogenesis of dry AMD |
| 2. | Incorporate current data on dietary supplements into communication and management strategies for patients with dry AMD |
| 3. | Discuss the efficacy and safety of agents currently in clinical trials for geographic atrophy |
| 4. | Compare the safety and efficacy of anti-VEGF therapies for wet AMD |
| 5. | Apply individualized management strategies for patients with wet AMD |
Last Review: September 25, 2015
This activity is jointly provided by Global Education Group and MedEdicus LLC.
Target Audience
This activity intends to educate retina specialists and other ophthalmologists who care for patients with wet and dry AMD.
Statement of Need/Program Overview
Treatment for age-related macular degeneration (AMD) is undergoing a significant paradigm shift with successful management of the wet form, and significant progress in understanding and treating the dry form is on the horizon. This activity will provide an update amongst clinicians in managing patients with wet AMD both in individualizing care for different patients who do not meet the criteria of clinical trials and in new developments related to safety of anti-VEGF agents.
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and MedEdicus. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this CME activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest
Global Education Group (Global) requires instructors, planners, managers, and other individuals and their spouses/life partners who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and MedEdicus. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this CME activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest
Global Education Group (Global) requires instructors, planners, managers, and other individuals and their spouses/life partners who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The faculty reported the following financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity:
| Name of Faculty | Reported Financial Relationship |
| Pravin U. Dugel, MD | Consultant/Independent Contractor: Abbott Medical Optics (AMO); Aerpio Therapeutics; Alcon, Inc; Alimera Sciences; Allergan, Inc; Annidis Corp; Acucela, Inc; Avalanche Biotechnologies, Inc; Clearside Biomedical, Inc; Digisight Technologies Inc; Dose Medical Corp; Genentech, Inc; Glaukos Corp; Lutronic Corp; Novartis Pharmaceuticals Corp; OD-OS Inc; Ophthotech Corp; Opthea Pty Ltd; Ora, Inc; Regeneron Pharmaceuticals, Inc; Roche USA; PentaVision LLC; Stealth BioTherapeutics Inc; ThromboGenics NV Stock Shareholder: Alimera Sciences; Annidis Corp; Aerpio Therapeutics; Ophthotech Corp; TrueVision |
| Carl Regillo, MD | Consultant/Independent Contractor: Genentech, Inc; ThromboGenics NV; Novartis Pharmaceuticals Corp; Acucela Inc Grant/Research Support: Genentech, Inc; ThromboGenics NV; Acucela Inc ; Regeneron Pharmaceuticals, Inc; GlaxoSmithKline; Ophthotech Corp |
| SriniVas R. Sadda, MD | Consultant/Independent Contractor: Genentech, Inc; Allergan, Inc; Optos; Carl Zeiss Meditec, Inc; StemCells, Inc Grant/Research Support: Genentech, Inc; Allergan, Inc; Optos; Carl Zeiss Meditec, Inc Honoraria: Topcon Medical Systems, Inc; Nidek Co., Ltd |
| Rishi Singh, MD | Consultant/Independent Contractor: Genentech, Inc; Regeneron Pharmaceuticals, Inc; Shire; Alcon, Inc |
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity:
| Name of Planner or Manager | Reported Financial Relationship |
| Diane McArdle, PhD | Nothing to disclose |
| Cynthia Tornallyay, RD, MBA, CCMEP | Nothing to disclose |
| Robert Geist, MD | Nothing to disclose |
| Randy Robbins | Nothing to disclose |
| Amanda Glazar, PhD | Nothing to disclose |
| Andrea Funk | Nothing to disclose |
| Supported Browsers: |
| Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8 |
| Google Chrome 28.0+ for Windows, Mac OS, or Linux |
| Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux |
| Safari 6.0+ for Mac OSX 10.7 and above |
| |
| For video playback, install the latest version of Flash or Quicktime. |
Instructions to Receive Credit
By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive 1.0 AMA PRA category 1 credits™.
- Read the learning objectives and faculty disclosures.
- Participate in the activity.
- Complete the post-test and activity evaluation.
- Physicians who successfully complete the post-test and evaluation will receive CME credit. You must score 70% or higher on the post-test to receive credit for this activity.
- All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
Global Contact Information
For information about the accreditation of this program, please contact Global at 303.395.1782 or inquire@globaleducationgroup.com.
For information about the accreditation of this program, please contact Global at 303.395.1782 or inquire@globaleducationgroup.com.
Fee Information& Refund/Cancellation Policy
There is no fee for this educational activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and MedEdicus LLC do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and MedEdicus LLC do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
